DaVita Profile

USD 0.92  1.34%

Acquisition by Pamela Arway of 135 shares of DaVita subject to Rule 16b-3

DaVita Inc insider trading alert for grant of common stock by Pamela Arway, the corporate stakeholder, on March 17, 2018. This event was filed by Davita Inc with SEC on 2010-07-29. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

DaVita Summary

DaVita Inc (DVA) is traded on New York Stock Exchange in USA. It is located in COLORADO, U.S.A and employs 74,500 people. DaVita is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 12.42 B. DaVita Inc runs under Healthcare sector within Healthcare Services industry. This company has 181.22 M outstanding shares of which 0 shares are currently shorted by investors with about 0.0 days to cover shorted positions. DAVITA INC has about 551.75 M in cash with 1.97 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.03.
Check DaVita Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected DaVita Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

DaVita Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 1% 
Equity ratings for DaVita Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease . DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado. DaVita operates under Specialized Health Services classification in USA and traded on New York Stock Exchange exchange. It employs 74500 people. more
Fama & French Healthcare
Fama & French Classification
NameDaVita Inc
CEO of Kidney Care DivisionJavier RodriguezView All
Thematic Classifications
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Healthcare Services
InstrumentUSA Stock View All
RegionNorth America
Business Address2000 16th Street
ExchangeNew York Stock Exchange
CIK Number00927066.0
IndustryHealthcare Services
Contact Number303 405 2100
CurrencyUSD - US Dollar


DaVita Analyst Recommendations
Target PriceAdvice# of Analysts
DaVita Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
DaVita Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


DaVita Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.82May 3, 2017
DaVita Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


DaVita Corporate Directors
Paul Diaz Independent Director
John Nehra Independent Director
Peter Grauer Lead Independent Director